Bruker (BRKR) Up 17.1% Since Last Earnings Report: Can It Continue?

03.12.25 17:30 Uhr

Werte in diesem Artikel
Aktien

40,74 EUR -0,71 EUR -1,71%

It has been about a month since the last earnings report for Bruker (BRKR). Shares have added about 17.1% in that time frame, outperforming the S&P 500.But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Bruker due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Bruker Corporation before we dive into how investors and analysts have reacted as of late.Bruker's Q3 Earnings and Revenues Top EstimatesBruker Corporation delivered adjusted earnings per share of 45 cents for the third quarter of 2025, down 25% year over year. However, the figure came 36.36% above the Zacks Consensus Estimate.           The adjustments include expenses related to the amortization of purchased intangibles, acquisition-related costs and restructuring costs, among others.Third quarter 2025 GAAP diluted loss per share was 41 cents, compared to diluted earnings per share of 27 cents in the year-ago period.BRKR’s Q3 RevenuesBruker's third-quarter revenues were $860.5 million, down 0.5% year over year. However, the figure topped the Zacks Consensus Estimate by 1.20%.BRKR’s 2025 GuidanceThe company has lowered its financial guidance for full-year 2025. Revenues are now expected in the range of $3.41 to $3.44 billion (previously $3.43 to $3.50 billion), suggesting 1% to 2% reported growth over 2024. The Zacks Consensus Estimate for revenues is pegged at $3.42 billion.Adjusted earnings per share for the year is expected in the range of $1.85 to $1.90 (previously $1.95 to $2.05). The consensus estimate for the same is pegged at $1.89.How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in fresh estimates.The consensus estimate has shifted -23% due to these changes.VGM ScoresCurrently, Bruker has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. Following the exact same course, the stock was allocated a score of D on the value side, putting it in the bottom 40% for value investors.Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Bruker has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bruker Corporation (BRKR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Bruker und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Bruker

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Bruker

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Bruker Corp

Wer­bung

Analysen zu Bruker Corp

DatumRatingAnalyst
24.06.2019Bruker Strong BuyNeedham & Company, LLC
30.05.2019Bruker Peer PerformWolfe Research
06.05.2019Bruker Strong BuyNeedham & Company, LLC
12.04.2019Bruker BuyDeutsche Bank AG
12.02.2019Bruker BuyBTIG Research
DatumRatingAnalyst
24.06.2019Bruker Strong BuyNeedham & Company, LLC
06.05.2019Bruker Strong BuyNeedham & Company, LLC
12.04.2019Bruker BuyDeutsche Bank AG
12.02.2019Bruker BuyBTIG Research
03.01.2019Bruker Strong BuyNeedham & Company, LLC
DatumRatingAnalyst
30.05.2019Bruker Peer PerformWolfe Research
18.01.2017Bruker HoldDeutsche Bank AG
04.01.2017Bruker Equal WeightBarclays Capital
05.05.2016Bruker NeutralMizuho
07.01.2016Bruker HoldDeutsche Bank AG
DatumRatingAnalyst
09.10.2018Bruker SellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Bruker Corp nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen